Profile
Richard G.
Horan is the founder of Sachem Ventures, founded in 1998.
Mr. Horan is currently the Chief Executive Officer & Director at Gila Therapeutics, Inc. and Director at GenEncap, Inc. Former positions include President & CEO at SEQ Ltd. from 1992 to 1997, Senior Managing Director at Slater Technology Fund, Inc. from 2002 to 2017, and Director roles at Bionica Corp., CytoSolv, Inc., Cadent Therapeutics, Inc., Medley Genomics, Inc., and Mindimmune Therapeutics, Inc. Formerly a Partner at Johnston Associates, Inc. from 1986 to 1997 and Principal at Bank of America Private Bank from 1980 to 1985.
Education includes undergraduate and graduate degrees from Dartmouth College.
Richard G. Horan active positions
| Companies | Position | Start |
|---|---|---|
GenEncap, Inc.
GenEncap, Inc. Medical SpecialtiesHealth Technology Develops and commercializes DNA sequencing technology | Director/Board Member | 2012-04-23 |
Gila Therapeutics, Inc.
Gila Therapeutics, Inc. Other Consumer ServicesConsumer Services Provides developing therapies for obesity patients | Chief Executive Officer | - |
Former positions of Richard G. Horan
| Companies | Position | End |
|---|---|---|
Slater Technology Fund, Inc.
Slater Technology Fund, Inc. Investment ManagersFinance Slater Technology Fund invests in companies located in the United States. The firm targets companies operating in the fields of software, technology, energy and life sciences sectors. It provides financing for seed and early stage capital requirements. | Private Equity Investor | 2016-12-31 |
Johnston Associates, Inc.
Johnston Associates, Inc. Investment ManagersFinance Johnston Associates invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It participates in seed, early and later stage transactions. | Corporate Officer/Principal | 1997-12-30 |
SEQ Ltd. | Chief Executive Officer | 1997-11-30 |
Bank of America Private Bank
Bank of America Private Bank Investment ManagersFinance The foundation of BAPB's equity selection process is proprietary research. They use a blend of qualitative and quantitative fundamental research to target large capitalization companies that have long-term growth potential, proven earnings track records, competitive advantages and strong management. Fixed-income investments are tailored to address client-specific needs for income and capital appreciation. | Corporate Officer/Principal | 1985-12-30 |
Medley Genomics, Inc.
Medley Genomics, Inc. Internet Software/ServicesTechnology Services Provides genomic analysis services to cancer patients through genome mapping platform | Director/Board Member | - |
Training of Richard G. Horan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Dartmouth College
Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnston Associates, Inc.
Johnston Associates, Inc. Investment ManagersFinance Johnston Associates invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It participates in seed, early and later stage transactions. | Finance |
Bank of America Private Bank
Bank of America Private Bank Investment ManagersFinance The foundation of BAPB's equity selection process is proprietary research. They use a blend of qualitative and quantitative fundamental research to target large capitalization companies that have long-term growth potential, proven earnings track records, competitive advantages and strong management. Fixed-income investments are tailored to address client-specific needs for income and capital appreciation. | Finance |
Slater Technology Fund, Inc.
Slater Technology Fund, Inc. Investment ManagersFinance Slater Technology Fund invests in companies located in the United States. The firm targets companies operating in the fields of software, technology, energy and life sciences sectors. It provides financing for seed and early stage capital requirements. | Finance |
GenEncap, Inc.
GenEncap, Inc. Medical SpecialtiesHealth Technology Develops and commercializes DNA sequencing technology | Health Technology |
Sachem Ventures
Sachem Ventures Investment ManagersFinance Sachem Ventures invest in companies located in the United States, primarily in New Haven. The firm targets companies operating across a broad range of sectors. It provides financing for early stage transactions with a investment size of USD 0.075 - 0.125 million. The firm does not invest in real estate. | Finance |
Bionica Corp.
Bionica Corp. Specialty TelecommunicationsCommunications Develops personal communication systems for the hearing-impaired people | Communications |
CytoSolv, Inc.
CytoSolv, Inc. Pharmaceuticals: OtherHealth Technology Develops proprietary technology to address wound healing | Health Technology |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders | Health Technology |
SEQ Ltd. | |
Gila Therapeutics, Inc.
Gila Therapeutics, Inc. Other Consumer ServicesConsumer Services Provides developing therapies for obesity patients | Consumer Services |
Medley Genomics, Inc.
Medley Genomics, Inc. Internet Software/ServicesTechnology Services Provides genomic analysis services to cancer patients through genome mapping platform | Technology Services |
Mindimmune Therapeutics, Inc.
Mindimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs that target immune system for treating diseases related to central nervous system | Health Technology |
- Stock Market
- Insiders
- Richard G. Horan
















